Subscribe to Newsletter

Supply Chain

Business & Regulation Supply Chain

The Early Bird Gets the…

| Joy Aho

What are the key decisions that need to be made for cell therapy supply chains?

Discovery & Development Business Practice

“We Want to Return to the Lab”: How the Russian Invasion Has Disrupted Drug Discovery in Ukraine

| Angus Stewart

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

Manufacture Advanced Medicine

SaudiVax: Regionalizing and Democratizing Cell & Gene Therapy

| Sponsored by MilliporeSigma

How SaudiVax is partnering to help patients in the Middle East and Africa to access advanced medicine.

Manufacture Supply Chain

Mapping out Material Resilience for Biopharmaceutical Supply Chains

| Sponsored by Thermo Fisher Scientific

A short guide to strengthening raw materials supply chains in the biopharma industry, featuring Luis Bianchi Pintos from Thermo Fisher Scientific.

Manufacture Advanced Medicine

The ABCs of Apheresis Infrastructure

| Lacey Anderson

Building and managing an advanced therapy collection network is a significant challenge, but there is another route.

Business & Regulation Packaging

Desert, Tundra, and Archipelago: a Vaccine Epic

What did the industry learn about logistics during COVID vaccine rollout, and how will it make sure nobody gets left behind?

Manufacture Ingredients

Don't Get a Raw Deal

| Hunter Malanson

While you’re busy scaling up your bioprocesses, don’t forget about the secure supply of all critical raw materials

Business & Regulation Supply Chain

The Value of Dogged Determination

| Banks Bourne

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

Business & Regulation Supply Chain

Building Resilience in the Supply Chain

| Sponsored by Thermo Fisher Scientific

We catch up with Christine Callahan from Thermo Fisher Scientific about how suppliers and customers need to reimagine their business models.

Business & Regulation Supply Chain

Strengthening Supply Chains Post-Pandemic

| Sponsored by Thermo Fisher Scientific

We spoke to Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, to ask what makes a strong supply chain.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register